News

Cephalon accepts Teva’s $6.8 billion takeover, again snubbing Valiant’s $5.7 billion bid

03-05-2011

US biotechnology firm Cephalon (Nasdaq: CEPH) has agreed to accept Israel generics giant Teva Pharmaceutical…

BiotechnologyCephalonMergers & AcquisitionsPharmaceuticalTeva Pharmaceutical IndustriesValeant Pharmaceuticals

COMPANY SPOTLIGHT

Menarini

Back to top